Track topics on Twitter Track topics that are important to you
COCONUT CREEK, FL--(Marketwired - February 22, 2017) - NutraFuels, Inc. ("NutraFuels" or "NTFU"), (OTC PINK: NTFU), today announced that the company is in the process of implementing clinical efficacy studies on the company's product line of oral spray nutraceuticals beginning with the company's Sleep Support oral spray containing CBD (Cannabidiol).
The clinical program will evaluate the absorption and efficacy of the company's unique oral spray nutraceutical products for common health and wellness uses, including sleep disorders, pain relief and others. The initial studies will describe the time course of absorption of melatonin and CBD (Cannabidiol) following a fixed single oral spray dose of Sleep Support in healthy volunteers. The second phase of this development program is to determine the effectiveness of NutraFuels Sleep Support Oral Spray on various sleep parameters in subjects with sleep disorders.
NutraFuels has engaged with clinical research and development experts to facilitate the setup process and execution of several studies specific to the company's product line of daily health and wellness oral sprays. The company plans to begin these studies within the second quarter of 2017. Once completed the company will then move forward with further studies to demonstrate the efficacy of the company's other naturally derived products that cater to various daily health and wellness uses.
"We are pleased to announce that we are taking the necessary steps to validate the efficacy and benefit of our products and look forward to producing conclusive data that will demonstrate the quality of the products we produce," said Edgar Ward, NutraFuels President/CEO.
About NutraFuels, Inc.
NTFU was founded in 2010, to manufacture, distribute and market a line of oral spray nutritional dietary products to consumers, retailers and wholesale outlets. Oral spray delivery systems are recognized by many as an effective methodology for delivery of pharmaceutical and nutraceutical products. Oral spray delivery is recognized by consumers for its convenience, dosage precision and timely assimilation into the body. NTFU's product line consists of vitamins and nutrients in an aqueous solution, orally delivered through a non-aerosol pump. NTFU's products are sprayed into the mouth in the form of a fine mist entering the delicate tissue of the mouth. The nutrients are delivered into the bloodstream and assimilated throughout the body more quickly than traditional methods, avoiding the solubility and absorption problems common with most ingested vitamins and nutritional supplements in pill or capsule form.
This press release contains forward-looking statements, particularly as related to, among other things, the business plans of NutraFuels, Inc, statements relating to goals, plans and projections regarding the NutraFuels' financial position and business strategy. The words or phrases "would be," "will allow," "intends to," "may result," "are expected to," "will continue," "anticipates," "expects," "estimate," "project," "indicate," "could," "potentially," "should," "believe," "think", "considers" or similar expressions are intended to identify "forward-looking statements." These forward-looking statements fall within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934 and are subject to the safe harbor created by these sections. Actual results could differ materially from those projected in the forward-looking statements as a result of a number of risks and uncertainties. Such forward-looking statements are based on current expectations, involve known and unknown risks, a reliance on third parties for information, transactions or orders that may be cancelled, and other factors that may cause our actual results, performance or achievements, or developments in our industry, to differ materially from the anticipated results, performance or achievements expressed or implied by such forward-looking statements. Factors that could cause actual results to differ materially from anticipated results include risks and uncertainties related to the fluctuation of global economic conditions, the performance of management and our employees, our ability to obtain financing, competition, general economic conditions and other factors that are detailed in our periodic reports and on documents we file from time to time with the Securities and Exchange Commission. Statements made herein are as of the date of this press release and should not be relied upon as of any subsequent date. NutraFuels cautions readers not to place undue reliance on such statements. NutraFuels does not undertake, and NutraFuels specifically disclaims any obligation, to update any forward-looking statements to reflect occurrences, developments, unanticipated events or circumstances after the date of such statement. Actual results may differ materially from NutraFuels' expectations and estimates.NutraFuels, Inc. 6601 Lyons Road, Suite L-6 Coconut Creek, FL 33073 Telephone: 754-227-5692 Email: NEXT ARTICLE
Sleep disorders disrupt sleep during the night, or cause sleepiness during the day, caused by physiological or psychological factors. The common ones include snoring and sleep apnea, insomnia, parasomnias, sleep paralysis, restless legs syndrome, circa...
Alternative Medicine Cleft Palate Complementary & Alternative Medicine Congenital Diseases Dentistry Ear Nose & Throat Food Safety Geriatrics Healthcare Hearing Medical Devices MRSA Muscular Dyst...
Pain is defined by the International Association for the Study of Pain as “an unpleasant sensory and emotional experience associated with actual or potential tissue damage or described in terms of such damage”. Some illnesses can be excruci...